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Abstract: Four new cyathane-type diterpenoids, nigernins C–F (1–4), together with four known compounds, were isolated from the 
fruiting bodies of the basidiomycete Phellodon niger. The structures of these new compounds were established on the basis of spec-
troscopic analysis, including 1D and 2D NMR experiments. In addition, nigernin F (4) with an unusual 3,4-seco cyathane diterpe-
noid skeleton was found to occur in nature for the first time. It was suggested to be as an oxidation product of C-3-C-4 bond cleav-
age of nigernin E (3). 
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Introduction 
Phellodon niger is an edible fungus belonging to the family 
Hydnaceae.1 In our continuing search for novel and secondary 
metabolites from higher fungi of Yunnan province in China, 
we have previously isolated two new cyathane diterpenoids, 
nigernins A and B from this fungus.2 Further research for the 
cyathane-type diterpenoids in the fruiting bodies of P. niger 
led to the isolation of four new cyathanes, nigernins C–F (1–4), 
along with four known compounds, sarcodonin δ,3 1,2-
diacetoxy-3-(4′-hydroxyphenyl)-4,7,8-trihydroxy-dibenzo-
furan (Bl-V),4 grifolic acid5 and uridine.6 Herein, we report the 
isolation and structure elucidation of the new compounds. 
 
Results and Discussion 
Compound 1 was isolated as white amorphous powder. The 
molecular formula was established to be C30H38O5 based on 
HREIMS at m/z 478.2701 [M]+ (calcd for C30H38O5 [M]+, 
478.2719), indicating twelve degrees of unsaturation. The IR 
spectrum showed the presence of a hydroxy (3423 cm−1) group, 
a benzene ring (1604, 1513, 1460 cm−1) and two carbonyl 
(1713, 1690 cm−1) groups. The 1H NMR spectrum (Table 1) 
indicated the presence of four methyls [δH 0.88 (3H, s, H-16); 
0.96 (6H, d, J = 6.7 Hz, H-19 and 20); 1.12 (3H, s, H-17)], a 
methoxyl group at δH 3.84 (3H, s, 4′-OCH3), a 1′,4′-
disubstituted benzene ring [δH 6.91 (2H, d, J = 8.7 Hz, H-3′ 
and 5′) and 7.49 (2H, d, J = 8.7 Hz, H-2′ and 6′)], a trans-
double bond [δH 6.34 (1H, d, J = 15.9 Hz, H-8′) and 7.69 (1H, 
d, J = 15.9 Hz, H-7′)], an olefinic proton at δH 7.22 (1H, d, J = 
7.1 Hz, H-13), and an oxymethine at δH 5.02 (1H, d, J = 7.1 
Hz, H-14). The 13C NMR spectrum of 1 (Table 1) revealed the 
presence of one p-methoxycinnamoyloxyl moiety [δC 55.4 (q), 
114.3 (d × 2), 115.1 (d), 127.0 (s), 129.8 (d × 2), 145.0 (d), 
161.5 (s), 166.5 (s)]. The remaining 20 carbons were 
ascribable for four methyls, six methylenes, four methines, 
five quaternary carbons, and one carbonyl group. Comparison 
of NMR data of 1 with those for nigernin A, previously 
isolated from this fungus,2 revealed the presence of the 
characteristic signals of a cyathane-type diterpenoid. The 
absence of a methylene resonance at δC 43.4 in the 13C NMR 
spectrum of nigernin A, and the appearance of the signals at δC 
77.8 and δH 5.02 (d, J = 7.1 Hz) in the NMR spectra of 1, 
suggested the existence of an oxygenated methine attributable 
to C-14 in 1. This was supported by the coupling constant (J = 
7.1 Hz) of H-13 at δH 7.22, and the HMBC correlations from 
H-14 to C-5, C-12 and C-13, and from H-16 to C-14 (Figure 
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1). In addition, the HMBC correlation from H-14 to C-9′ 
suggested that the p-methoxycinnamoyloxyl ester unit was 
linked to C-14. The ROESY correlations between H-5 and H-
17, H-17 and H-8, H-16 and H-8, H-16 and H-14 were 
observed in 1. It indicated H-14 to be α-oriented (Figure 2). 
Thus, the structure of 1 was elucidated as 14β-(p-
methoxycinnamoyloxyl)-cyatha-3,12-diene-15-oic acid, and 
named as nigernin C. 
Compound 2 was obtained as white amorphous powder, 
giving the molecular formula C30H40O5 by the HREIMS at m/z 
480.2880 [M]+ (calcd for C30H40O5, [M]+, 480.2876). The 
NMR spectral data of 2 (Table 1) were very similar to those of 
1, suggesting that 2 was also a cyathane diterpenoid. The key 
difference was the double bond in p-methoxycinnamoyloxyl 
unit of 1 replaced by two methylenes in 2. This was confirmed 
by the HMBC spectrum, which showed correlations of H-7′ 
with C-1′, C-2′, C-6′, C-8′ and C-9′, and of H-8′ with C-1′, C-7′ 
and C-9′. In addition, correlation from δH 4.86 (1H, d, J = 7.2 
Hz, H-14) to δC 172.3 (s, C-9′) was also observed in the 
HMBC spectra, indicating that the 3-(4-
methoxyphenyl)propanoyloxyl ester unit was also linked to C-
14 of the cyathane skeleton. The stereochemistry of 2 was in 
accordance with 1 by the analysis of the ROESY spectrum. 
Consequently, the structure of 2 was determined as 14β-(3-(4-
methoxyphenyl)propanoyloxyl)-cyatha-3,12-diene-15-oic acid, 
and named as nigernin D. 
Compound 3 was isolated as white amorphous powder. Its 
molecular formula was determined to be C28H36O5 on the basis 
of molecular ion peak at m/z 452.2554 in the HREIMS (calcd 
for C28H36O5 [M]+, 452.2563), in combination with the 13C 
NMR and DEPT spectra. The 1H and 13C NMR spectroscopic 
data of 3 (Table 1) were very similar to those of 1, except for a 
p-methoxybenzoyloxyl group in 3 instead of the p-
methoxycinnamoyloxyl group in 1. The proton signals at δH 
6.94 (2H, d, J = 8.9 Hz, H-3′ and 5′) and 8.04 (2H, d, J = 8.9 
Hz, H-2′ and 6′) in the 1H NMR spectrum, together with the 
13C-NMR signals at δC 55.5 (q), 113.8 (d × 2), 122.4 (s), 131.7 
(d × 2), 163.5 (s), 165.5 (s) were determined readily as a p-
methoxybenzoyloxyl unit. The location of the substituent and 
the stereochemistry of 3 were the same as those in 1 on the 
basis of analysis of HMBC and ROESY data. Therefore, 
compound 3 was identified as 14β-(p-methoxybenzoyloxyl)-
cyatha-3,12-diene-15-oic acid, and named as nigernin E. 
Compound 4 was obtained as white, amorphous powder and 
assigned the molecular formula C28H36O7 as deduced by 
HREIMS (found m/z 484.2450 [M]+, calcd for C28H36O7 [M]+, 
484.2461). Comparison of the 1H and 13C NMR data of 4 (Ta-
ble 1) with those of 3 indicated that their structures were simi-
lar. The main differences between these two compounds were 
the appearance of two keto carbonyl signals at δC 215.0 (s, C-3) 
and 215.5 (s, C-4) in 4 and the absence of two olefinic quater-
nary carbons [δC 140.4 (s, C-3) and 138.1(s, C-4)] in 3. In 
addition, the EIMS of 4 with molecular ion peak [M]+ at m/z 
484 suggested more 32 mass units than that of 3. On the basis 
of above evidence and the literature,7 compound 4 should be a 
3,4-seco cyathane diterpenoid due to an oxidation cleavage of 
C-3-C-4 double bond of 3. This was also confirmed by HMBC 
correlations (Figure 1) from H-2, H-18, H-19 and H-20 to C-3, 
and from H-5 and H-17 to C-4. The ROESY (Figure 2) corre-
lations between H-5 and H-17 of 4 indicated that the methyl at 
C-9 is . Therefore, the structure of 4 was determined to be 
3,4-seco nigernin E, and named as nigernin F. To the best of 
our knowledge, this is the first report of the 3,4-seco cyathane 
skeleton from nature. 
 
Experimental Section 
General Experimental Procedures. Optical rotations were 
measured with a Horiba SEPA-300 polarimeter. UV spectra 
were recorded on a Shimadzu UV-2401PC spectrophotometer. 
IR spectra were obtained on a Bruker Tensor 27 spectrometer 
with KBr pellets. NMR spectra were recorded on a Bruker 
AV-400 or a DRX-500 spectrometer with TMS as an internal 
standard. EIMS and HREIMS were recorded on a VG Au-
tospec-3000 mass spectrometer. Silica gel (200-300 mesh, 
Qingdao Marine Chemical Inc., China) and Sephadex LH-20 
(Amersham Biosciences, Sweden) were used for column 
chromatography. HPLC was performed on an Agilent 1100 
liquid chromatography system equipped with a Zorbax SB-C18 
column (9.4 mm × 150 mm). TLC was performed on silica gel 
plates (GF254, Qingdao Marine Chemical Inc., China). The 
 
Figure 1.  Key 1H,1H-COSY and HMBC correlations of 1 and 4. 
 
Figure 2. Key ROESY correlations of compounds 1 and 4.
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spots on TLC were visualized by UV light (254/365 nm) and 
sprayed with 10% H2SO4 in ethanol, followed by heating. 
 
Fungal Material. The basidiomycete P. niger was collected 
at Wuding of Yunnan Province in August 2009, and identified 
by Prof. Zhu-Liang Yang, Kunming Institute of Botany. The 
voucher specimen was deposited at the Herbarium of Kunming 
Institute of Botany, Chinese Academy of Sciences. 
 
Extraction and Isolation. The air-dried fruiting bodies 
(950 g) were extracted three times with CHCl3/MeOH (1:1, 
v/v) at room temperature. After removal of the solvent by 
evaporation, the residue (98.0 g) was subjected to silica gel 
column eluted with a petroleum ether-acetone gradient system 
(1:0–1:1, v/v) to give fractions A–I. Fraction E was subjected 
to Sephadex LH-20 using CHCl3-MeOH (1:1, v/v) to give 4 
subfractions: E1–E4. Subfraction E3 was further purified by 
silica gel chromatography (CHCl3/MeOH, 50:1) and prepara-
tive HPLC (CH3CN/H2O, 65:35) to obtain 2 (9.6 mg) and 3 
(18.3 mg). Compound 4 (13.2 mg) was purified from subfrac-
tion E2 by preparative HPLC (CH3CN/H2O, 40:60). Fraction F 
was passed through Sephadex LH-20 using CHCl3/MeOH (1:1, 
v/v) and repeated column chromatography over silica gel, and 
finally purified by preparative HPLC using a mobile phase of 
CH3CN/H2O (75:25 and 65:35) to afford 1 (16.2 mg) and gri-
folic acid (12.3 mg), respectively. Sarcodonin δ (17.0 mg) was 
purified from fraction G by repeated silica gel column chroma-
tography. Fraction H was subjected to silica gel, Sephadex 
LH-20, and preparative HPLC to give 1,2-diacetoxy-3-(4′-
hydroxyphenyl)-4,7,8-trihydroxy-dibenzofuran (5.4 mg). Frac-
tion I was separated over silica gel eluted with CHCl3/MeOH 
(10:1), and then further purified by preparative HPLC to af-
Table 1. 1H and 13C NMR (400/100MHz) data of 1–4 in CDCl3 (δ in ppm, J in Hz). 
Pos. 1 2 3 4 
δH δC δH δC δH δC δH δC 
1 1.59, m; 1.51, m 37.8, CH2 1.56, m; 1.47, mb 37.7, CH2 1.59, m; 1.50, m 37.8, CH2 1.70, t (7.4) 32.2, CH2
2 2.29, t (7,5) 28.5, CH2 2.26, t (7.5) 28.5, CH2 2.29 (t, 7.6) 28.6, CH2 2.53, m; 2.45, m 35.4, CH2
3  140.3, qC  140.3, qC  140.5, qC  215.0, qC
4  138.2, qC  138.1, qC  138.1, qC  215.5, qC
5 3.06, m 44.0, CH 2.91, m 43.8, CH 3.17, m 44.2, CH 3.46, m 51.6, CH
6  41.5, qC  41.2, qC  41.6, qC  43.9, qC
7 1.99, m 
1.18 br, d (13.5) 
33.9, CH2 1.77, td (13.4, 4.3) 
1.04, m 
33.8, CH2 2.04, m  
1.19 br, d (13.8) 
34.1, CH2 2.38, m 
1.37, d (13.5) 
32.2, CH2
8 1.55, m 
1.42 br, d (13.5) 
36.5, CH2 1.47, mb 
1.34 br, d (11.8) 
36.4, CH2 1.54, m  
1.40 br, d (12.5) 
36.5, CH2 1.78, m 
1.59, m 
33.1, CH2
9  49.2, qC  49.1, qC  49.2, qC  46.2, qC
10 1.98, m 26.2, CH2 1.90, m 26.2, CH2 2.00, m 26.4, CH2 1.94 br, d (13.7) 
1.50, m 
21.0, CH2
11 2.81, dt (15.5, 4.5) 
2.57, m 
25.7, CH2 2.72 br, d (15.4) 
2.34, m 
25.6, CH2 2.82 br, d (15.9) 
2.56, m 
25.8, CH2 2.91, dd (15.9, 4.5) 
2.39, m 
24.2, CH2
12  136.6, qC  136.8, qC  136.9, qC  137.7, qC
13 7.22, d (7.1) 141.6, CH 7.10, d (7.2)c 140.9, CH 7.25, d (7.3) 141.4, CH 7.22, d (7.3) 139.8, CH
14 5.02, d (7.1) 77.8, CH 4.86, d (7.2) 78.0, CH 5.09, d (7.3) 78.0, CH 5.15, d (7.3) 76.5, qC
15  172.5, qC  171.5, qC  172.3, qC  171.3, qC
16 0.88, s 16.5, CH3 0.80, s 16.4, CH3 0.90, s 16.5, CH3 0.83, s 16.8, CH3
17 1.12, s 24.3, CH3 1.03, s 24.2, CH3 1.11, s 24.3, CH3 1.23, s 23.6, CH3
18 3.00, m 26.8, CH 2.95, m 26.8, CH 3.01, m 26.8, CH 2.63, m 40.9, CH
19 0.96, d (6.7) 21.9, CH3a 0.93, d (6.7) 21.9, CH3a 0.96, d (6.7) 21.9, CH3a 1.09, d (6.9) 18.3, CH3
20 0.96, d (6.7) 21.7, CH3a 0.93, d (6.7) 21.6, CH3a 0.96, d (6.7) 21.7, CH3a 1.09, d (6.9) 18.3, CH3
1′  127.0, qC  132.2, qC  122.4, qC  121.9, qC
2′ 7.49, d (8.7) 129.8, CH 7.10, d (6.7)b 129.2, CH 8.04, d (8.9) 131.7, CH 8.01, d (8.5) 131.6, CH
3′ 6.91, d (8.7) 114.3, CH 6.81, d (6.7) 113.9, CH 6.94, d (8.9) 113.8, CH 6.95, d (8.5) 114.0, CH
4′  161.5, qC  158.1, qC  163.5, qC  163.7, qC
5′ 6.91, d (8.7) 114.3, CH 6.81, d (6.7) 113.9, CH 6.94, d (8.9) 113.8, CH 6.95, d (8.5) 114.0, CH
6′ 7.49, d (8.7) 129.8, CH 7.10, d (6.7)b 129.2, CH 8.04, d (8.9) 131.7, CH 8.01, d (8.5) 131.6, CH
7′ 7.69, d (15.9) 145.0, CH 2.93, t (7.6) 30.3, CH2  165.5, qC  165.2, qC
8′ 6.34, d (15.9) 115.1, CH 2.66, t (7.6) 36.2, CH2     
9′  166.5, qC  172.3, qC     
OCH3 3.84, s 55.4, CH3 3.78, s 55.2, CH3 3.86, s 55.5, CH3 3.87, s 55.5, CH3
aInterchangeable assignments. bOverlapping resonances. 
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ford uridine (2.6 mg). 
 
Nigernin C (1): white amorphous powder; [α]20D − 26.7 (c 
0.27, MeOH); UV (MeOH) λmax (log ε): 311 (4.09), 223 (3.97) 
nm; IR (KBr) νmax: 3423, 2958, 2935, 2866, 1713, 1690, 1604, 
1513, 1460, 1252, 1170, 999, 828 cm−1; 1H and 13C NMR data, 
see Table 1; EIMS m/z 478 [M]+; HREIMS m/z 478.2701 [M]+ 
(calcd for C30H38O5 [M]+, 478.2719). 
 
Nigernin D (2): white amorphous powder; [α]20D − 2.64 (c 
0.24, MeOH); UV (MeOH) λmax (log ε): 223 (3.85) nm; IR 
(KBr) νmax: 3432, 2955, 2934, 2866, 1690, 1613, 1514, 1461, 
1248 cm−1; 1H and 13C NMR data, see Table 1; EIMS m/z 480 
[M]+; HREIMS m/z 480.2880 [M]+ (calcd for C30H40O5 [M]+, 
480.2876). 
 
Nigernin E (3): white amorphous powder; [α]20D − 37.0 (c 
0.21, MeOH); UV (MeOH) λmax (log ε): 258 (3.94) nm; IR 
(KBr) νmax: 3424, 2958, 2936, 2866, 1717, 1690, 1607, 1511, 
1459, 1257, 1167, 1098 cm−1; 1H and 13C NMR data, see Table 
1; EIMS m/z 452 [M]+; HREIMS m/z 452.2554 [M]+ (calcd for 
C28H36O5 [M]+, 452.2563). 
 
Nigernin F (4): white amorphous powder; [α]20D + 33.4 (c 
0.21, MeOH); UV (MeOH) λmax (log ε): 259 (4.01) nm; IR 
(KBr) νmax: 3434, 2968, 2936, 2871, 1710, 1606, 1512, 1462, 
1258, 1167, 1098 cm−1; 1H and 13C NMR data, see Table 1; 
EIMS m/z 484 [M]+; HREIMS m/z 484.2450 [M]+ (calcd for 
C28H36O7 [M]+, 484.2461). 
 
Cytotoxicity Assay. The cytotoxicity assay against C8166 
cells (CC50) was assessed using the MTT method and anti-
HIV-1 activity was evaluated by the inhibition assay for the 
cytopathic effects of HIV-1 (EC50).19 
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